Cliff Asness's FLGT Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 29,444 shares of Fulgent Genetics, Inc. (FLGT) worth $468,160, representing 0.00% of the portfolio. First purchased in 2020-Q3, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in FLGT, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2022, adding 65,682 shares. Largest reduction occurred in Q2 2023, reducing 112,949 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Fulgent Genetics (FLGT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Fulgent Genetics (FLGT) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +29,444 | New Buy | 29,444 | $15.90 |
| Q2 2023 | -112,949 | Sold Out | 0 | $0.00 |
| Q1 2023 | -48,502 | Reduce 30.04% | 112,949 | $31.22 |
| Q4 2022 | +65,682 | Add 68.58% | 161,451 | $29.78 |
| Q3 2022 | +56,562 | Add 144.27% | 95,769 | $38.12 |
| Q2 2022 | +4,824 | Add 14.03% | 39,207 | $54.53 |
| Q1 2022 | +19,385 | Add 129.25% | 34,383 | $62.41 |
| Q4 2021 | +2,916 | Add 24.14% | 14,998 | $100.61 |
| Q3 2021 | -1,241 | Reduce 9.31% | 12,082 | $89.97 |
| Q2 2021 | +6,444 | Add 93.68% | 13,323 | $92.25 |
| Q1 2021 | -3,222 | Reduce 31.90% | 6,879 | $96.67 |
| Q4 2020 | -3,894 | Reduce 27.82% | 10,101 | $52.07 |
| Q3 2020 | +13,995 | New Buy | 13,995 | $40.01 |
Cliff Asness's Fulgent Genetics Investment FAQs
Cliff Asness first purchased Fulgent Genetics, Inc. (FLGT) in Q3 2020, acquiring 13,995 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Fulgent Genetics, Inc. (FLGT) for 13 quarters since Q3 2020.
Cliff Asness's largest addition to Fulgent Genetics, Inc. (FLGT) was in Q4 2022, adding 161,451 shares worth $4.81 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 29,444 shares of Fulgent Genetics, Inc. (FLGT), valued at approximately $468,160.
As of the Q1 2026 filing, Fulgent Genetics, Inc. (FLGT) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Fulgent Genetics, Inc. (FLGT) was 161,451 shares, as reported at the end of Q4 2022.